Stocks
SeaStar Medical Holding CorporationICUCW
NASDAQHealthcareMedical Devices$0.02
Price as of · delayed, not real-time
A commercial-stage medical device company developing extracorporeal therapies for hyperinflammation and organ failure. Its lead product, the SCD (Selective Cytopheretic Device), is designed to modulate the immune response in critically ill patients with acute kidney injury and other inflammatory conditions. Investors track the company for its progress through FDA regulatory pathways and early commercialization efforts.
52W Range: $0.02-$0.02
Congressional Interest in SeaStar Medical Holding Corporation (ICUCW)
No congressional trades have been disclosed for SeaStar Medical Holding Corporation (ICUCW) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ICUCW?
No congressional trades found for this stock.